| Dr Michelle Lauren Gravener, PHD, PA-C | |
|
500 University Dr, Hershey, PA 17033-2360 | |
| (717) 531-6597 | |
| (717) 531-7790 |
| Full Name | Dr Michelle Lauren Gravener |
|---|---|
| Gender | Female |
| Speciality | Neurological Surgery |
| Location | 500 University Dr, Hershey, Pennsylvania |
| Accepts Medicare Assignments | Medicare enrolled and may accept medicare through third-party reassignment. May prescribe medicare part D drugs. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1972280311 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207T00000X | Neurological Surgery | MA064590 (Pennsylvania) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Dr Michelle Lauren Gravener, PHD, PA-C Po Box 858, Mc A410, Hershey, PA 17033-0858 Ph: (800) 243-1455 | Dr Michelle Lauren Gravener, PHD, PA-C 500 University Dr, Hershey, PA 17033-2360 Ph: (717) 531-6597 |
News Archive
When the process goes awry, neurodevelopmental disorders such as mental retardation, dyslexia or autism may result. Researchers at the University of North Carolina at Chapel Hill School of Medicine have now discovered that establishing the neural wiring necessary to function normally depends on the ability of neurons to make finger-like projections of their membrane called filopodia.
Researchers from the University of Jyväskylä in Finland have found that continued treatment of muscle wasting with a soluble growth factor receptor protein, produced at the University of Helsinki, improved survival in a pre-clinical cancer model without affecting the tumor size.
Beckman Coulter Life Sciences is introducing the HIAC PODS+ Liquid Particle Counter, with advanced features for the early detection of minute contaminants.
Spectrum Pharmaceuticals, a biotechnology company with fully integrated commercial and drug development operations with a primary focus in hematology and oncology, today announced that the United States Patent and Trademark Office (USPTO) has extended by five years the U.S. Patent No. 6,028,071, which covers FOLOTYN (pralatrexate injection).
The Harvard Clinical Research Institute (HCRI) announced today that the enrollment phase of the DAPT Study has been successfully completed. The DAPT Study is a four-year clinical trial investigating the duration of dual antiplatelet therapy (DAPT, the combination of aspirin and a thienopyridine/antiplatelet medication to reduce the risk of blood clots) following drug-eluting stent implantations.
› Verified 7 days ago
Christopher Lowry Schaiberger, M.D. Neurological Surgery Medicare: Not Enrolled in Medicare Practice Location: 500 University Dr, Hershey, PA 17033 Phone: 800-233-4082 | |
Kimberly S Harbaugh, MD Neurological Surgery Medicare: Accepting Medicare Assignments Practice Location: 30 Hope Dr Ste 1200, Hershey, PA 17033 Phone: 717-531-3828 Fax: 717-531-0793 | |
Haejoe Park, MD, MS Neurological Surgery Medicare: Accepting Medicare Assignments Practice Location: 500 University Dr, Hershey, PA 17033 Phone: 800-243-1455 Fax: 717-531-0793 | |
Mark S Dias, MD Neurological Surgery Medicare: Accepting Medicare Assignments Practice Location: 500 University Dr, Hershey, PA 17033 Phone: 800-243-1455 | |
Steven J Schiff, M.D. Neurological Surgery Medicare: Not Enrolled in Medicare Practice Location: 500 University Dr, Hershey, PA 17033 Phone: 800-233-4082 | |
Dr. Michael David Sather, MD Neurological Surgery Medicare: Accepting Medicare Assignments Practice Location: 30 Hope Dr Ste 1200, Hershey, PA 17033 Phone: 717-531-3828 Fax: 717-531-0793 | |
Joseph Christopher Zacko, MD Neurological Surgery Medicare: Accepting Medicare Assignments Practice Location: 30 Hope Dr, Ec110, Hershey, PA 17033 Phone: 717-531-0895 Fax: 717-531-3858 |